[ACRS] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
12-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -26.07%
YoY- -99.86%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 1,628 3,676 1,118 999 684 0 0 -
PBT -32,740 -31,218 -30,229 -24,764 -18,192 -14,838 -12,559 89.30%
Tax 0 1,500 0 -1,830 0 0 0 -
NP -32,740 -31,218 -30,229 -22,934 -18,192 -14,838 -12,559 89.30%
Tax Rate - - - - - - - -
Total Cost 34,368 34,894 31,347 23,933 18,876 14,838 12,559 95.52%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin -2,011.06 -849.24 -2,703.85 -2,295.70 -2,659.65 0.00 0.00 -
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
EPS -1.06 -1.01 -0.98 -0.74 -0.63 -0.56 -0.48 69.49%
EPS Diluted -1.06 -1.01 -0.98 -0.74 -0.63 -0.56 -0.48 69.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.